Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

STERIS CEO: Walter M. Rosebrough Jr. is named president and CEO of the sterilization systems manufacturer, effective Oct. 1. Rosebrough replaces Les C. Vinney, who announced plans to step down last year. Vinney will continue to serve as special advisor to the company until his retirement in 2009. Rosebrough has more than 20 years experience in the health care industry, including top positions as Hill-Rom and health care start-up Vasocor. He is stepping down as president and CEO of family-owned Coastal Hydraulics

You may also be interested in...



People In Brief

The latest moves by movers and shakers in the medical device and diagnostics industries

Cautious Report Unlikely To Slow Partial-Breast Irradiation Market, Firms Say

In its most recent assessment of accelerated partial-breast irradiation (APBI), the BlueCross BlueShield Association Technology Evaluation Center reiterated that APBI as the sole radiation treatment following breast-conserving surgery for early stage cancer has not been proven beneficial. But companies in the budding APBI market say the report does not deter them from marketing or developing their treatments (see chart: "1FDA-Cleared APBI Devices ")

Mergers & Acquisitions In Brief

Ecolab's Microtek deal focuses on infection prevention: Acquisition of Microtek Medical for $274 million is intended to expand Ecolab's infection prevention offerings, Ecolab announces Aug. 7. Microtek's surgical drapes, disposable linens, and fluid and medical waste management equipment will dovetail with Ecolab's surface disinfectants, instrument cleaning detergents and surgical hand scrubs. Microtek reported second quarter revenue of $38.5 million, up 6.8%. Ecolab, with Q2 sales of $1.4 billion (up 11%) bills itself as "the world's leading provider of cleaning, food safety and health protection products and services". Ecolab will pay $6.30 in cash for each of Microtek's 43.5 million shares outstanding - representing a 34% premium over Microtek stock's Aug. 7 closing price of $4.69...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel